Guillaume Corpart
Managing Director
Global Health Intelligence
View from the Top

Big Data Already Changing Healthcare Sector

Wed, 09/05/2018 - 10:30

Q: What approach does Global Health Inteligence use to convert data analysis into growth opportunities?

A: Mexico has a large information gap related to the flow of data that suggests two problems: there is little information available and the existing data is unreliable. At Global Health Intelligence, we collect our own data through our call centers and we transform this data into information. Our data analytics allow pharmaceutical manufacturers, medical device manufacturers, equipment providers and IT solutions players to obtain information that is truly valuable. Pharmaceutical companies are sophisticated and base a majority of their decisions on reliable data. Medical device and equipment manufacturers are not used to having data or information and are used to making decisions with little data, often based on expert opinions.

Q: How can companies improve by using data analysis provided by Global Health Intelligence?

A: The most sophisticated companies we work for, such as GE, BD, Phillips, Olympus or Boston Scientific, take our data and transform it into commercial protocols. Also, depending on the services they hire, they can better understand the size of the market, the market share and the positioning of their competition to better position themselves for certain opportunities.

Q: What makes Global Health Intelligence's services the best options for companies looking to expand their business?

A: Our services are the best in the market and we are continuously improving them to provide more quality to our customers. HospiScope helps define the hospital landscape and we have profiles on over 18,000 hospitals in Latin America. For example, if a medical equipment company wants to sell an X-ray machine to a hospital, We can say exactly how many machines there are in each of 14 countries and in which hospitals they are installed. ShareScope is a tool that provides information about market size and market share, both per player and per product. SurgiScope looks at procedure volumes and tells the client how many procedures are conducted by type and by hospital. In-Scope delivers information on the market landscape that allows companies to search for market size segmentation and potential partners. Through In-Scope we also conduct due diligence, competitive profiles, tariffs and cost analyses to support our clients’ strategic decisions.

Q: What actions and partnerships does Global Health Intelligence carry out to guarantee the quality of its services?

A: One of our biggest challenges is that every country handles information differently, so the level and type of data are very different. Therefore, we try to standardize data as much as possible. Our call centers can control the entry of information and then pass the data to a team that is in charge of the data collection. We then structure the data with procedure codes according to the country and finally we standardize them.

Q: What is the difference between collecting data for the public and private sectors?

A: The problem for data collection in Mexico is that the private sector does not share information, so there is little data available. We collect as much information as possible and then build statistical models to complement. We also cross-check and validate through complementary databases. It is a challenge because there is no single procedural code.

Q: How do digital solutions and connectivity help the industry grow?

A: Mexico lacks infrastructure when compared to the regional average, particularly when comparing to countries such as Brazil and Colombia. Greater infrastructure is the first step and directly correlated to being able to offer more high-specialty care. Countries that do not have this level of infrastructure tend to focus on general procedures like OBGYN (obstetrician-gynecologist). Mexico needs to develop better infrastructure to then be able to increase access to higher specialty care.